Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation

Marwa El-Hussienya Organometallic and Organometalloid Chemistry Department, National Research Centre, Giza, EgyptCorrespondence[email protected] [email protected]
View further author information

Mansoura A. Abd-El-Maksouda Organometallic and Organometalloid Chemistry Department, National Research Centre, Giza, EgyptView further author information

Fouad M. Solimana Organometallic and Organometalloid Chemistry Department, National Research Centre, Giza, EgyptView further author information

Marwa A. Fouadb Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt;c Pharmaceutical Chemistry Department, School of Pharmacy, NewGiza University, Cairo, EgyptView further author information

Mohamed K. El-Ashreyb Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, EgyptCorrespondence[email protected]
View further author information

Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date